MARSHALL WACE, LLP - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 107 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$2,748,456
-40.0%
158,230
-51.4%
0.01%
-33.3%
Q2 2023$4,583,631
-47.2%
325,542
-59.7%
0.01%
-50.0%
Q1 2023$8,681,437
+291.7%
806,825
+445.4%
0.02%
+260.0%
Q4 2022$2,216,126
+169.9%
147,939
+112.2%
0.01%
+150.0%
Q4 2021$821,000
-40.7%
69,723
-11.0%
0.00%
-71.4%
Q4 2020$1,384,000
-39.1%
78,352
-47.2%
0.01%
-53.3%
Q3 2020$2,272,000148,3030.02%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q1 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,025,000$12,064,0002.56%
GREAT POINT PARTNERS LLC 536,738$6,317,0001.40%
Endurant Capital Management LP 244,125$2,873,0000.69%
HHLR ADVISORS, LTD. 2,920,023$34,369,0000.53%
Integral Health Asset Management, LLC 140,000$1,648,0000.46%
Spearhead Capital Advisors, LLC 235,024$2,766,0000.33%
Jackson Creek Investment Advisors LLC 77,069$907,0000.32%
RICE HALL JAMES & ASSOCIATES, LLC 712,807$8,390,0000.30%
Parkman Healthcare Partners LLC 113,644$1,338,0000.30%
Birchview Capital, LP 30,000$353,0000.23%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders